IRIS

Sfoglia per Rivista  

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 70 a 89 di 93
Titolo Data di pubblicazione Autore(i) File
Preservation of axillary lymph nodes compared to complete dissection in T1-T2 breast cancer patients presenting 1-2 metastatic sentinel lymph nodes: A multicenter randomized clinical trial. Sinodar One Stud 1-gen-2020 Tinterri, C
Preservation of axillary lymph nodes compared to complete dissection in T1-T2 breast cancer patients presenting 1-2 metastatic sentinel lymph nodes: A multicenter randomized clinical trial. Sinodar One Study 1-gen-2020 Tinterri, C; Marrazzo, E; Frusone, F; Gatzemeier, W; Barbieri, E; Sagona, A; Bottini, A; Errico, V; Testori, A; Canavese, G
Pretargeted Dual-Modality Immuno-SPECT and Near-Infrared Fluorescence Imaging for Image-Guided Surgery of Prostate Cancer 1-gen-2014 Lutje, S; Rijpkema, M; Goldenberg, Dm; van Rij, Cm; Sharkey, Rm; Mcbride, Wj; Franssen, Gm; Frielink, C; Helfrich, W; Oyen, W; Boerman, Oc
Pretargeted immunoPET for imaging human colonic cancer in a mouse model 1-gen-2011 Schoffelen, R; Franssen, Gm; Mcbride, Wj; Disselhorst, Ja; Sharkey, Rm; Laverman, P; van der Graaf, Wta; Oyen, W; Goldenberg, Dm; Boerman, Oc
Pretargeted radioimmunotherapy of an anti-CEA bispecific antibody and Lu-177-labeled peptide: a phase I study in patients with advanced colorectal cancer 1-gen-2012 Schoffelen, R; Boerman, Oc; Goldenberg, Dm; Sharkey, Rm; Herpen, Cml; Chang, Ch; Franssen, Gm; Mcbride, Wj; Rossi, Ea; van der Graaf, Wta; Oyen, W
Pretargeting of renal cell carcinoma: Improved tumor targeting with a bivalent chelate 1-gen-1999 Boerman, Oc; Kranenborg, Mhgc; Oosterwijk, E; Griffiths, Gl; Mcbride, Wj; Oyen, W; de Weijert, M; Oosterwijk-Wakka, J; Hansen, Hj; Corstens, Fhm
Prognostic Value of mib-1 in Patients with Early Invasive Breast Cancer and Its Correlation with Other Biologic Parameters in a Monoinstitutional Series 1-gen-2009 Ferro, A; Barbareschi, M; Eccher, C; Caldara, A; Frisinghelli, M; Triolo, R; Aldovini, D; Pellegrini, M; Bernardi, D; Galligioni, E
Proliferation of transformed somatotroph cells related to low or absent expression of protein kinase A regulatory subunit 1A protein 1-gen-2004 Lania, A; Mantovani, G; Ferrero, S; Pellegrini, C; Bondioni, S; Peverelli, E; Braidotti, P; Locatelli, M; Zavanone, Ml; Ferrante, E; Bosari, S; Beck-Peccoz, P; Spada, A
Prostate stem cell antigen is associated with gastric cancer in Caucasians: Results from the EPIC-EURGAST study 1-gen-2011 Sala, N; Munoz, X; Travier, N; Agudo, A; Duell, Ej; Moreno, V; Garcia, N; Capeila, G; Riboli, E; Gonzalez, Ca
PTX-008, a dual inhibitor of angiogenesis and tumor cell proliferation, potentiates the antineoplastic activity of targeted therapies in human tumor models 1-gen-2011 Bonezzi, K; Frapolli, R; Sala, F; Astorgues-Xerri, L; Serova, M; Raymond, E; Cvitkovic, E; Noel, K; Ubezio, P; Zucchetti, M; D'Incalci, M; Giayazzi, R; Taraboletti, G
Quantitative Assessment of the Complex Dynamics of G(1), S, and G(2)-M Checkpoint Activities 1-gen-2009 Ubezio, P; Lupi, M; Branduardi, D; Cappella, P; Cavallini, E; Colombo, V; Matera, G; Natoli, C; Tomasoni, D; D'Incalci, M
Second primary tumors after breast cancer: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC) study 1-gen-2012 Ricceri, F; Sacerdote, C; Critelli, R; Vineis, P; Riboli, E
Selective expression and constitutive phosphorylation of SHC proteins [corrected] in the CD34+ fraction of chronic myelogenous leukemias 1-gen-2000 Bonati, A.; Carlo-Stella, C.; Lunghi, P.; Albertini, R.; Pinelli, S.; Migliaccio, E.; Sammarelli, G.; Savoldo, B.; Tabilio, A.; Dall'Aglio, P. P.; Pelicci, P. G.
Specific histone patterns and acetylase/deacetylase activity at the breakpoint-cluster region of the human MLL gene 1-gen-2004 Khobta, A.; Carlo Stella, C.; Capranico, G.
Stepwise neoplastic transformation of a telomerase immortalized fibroblast cell line 1-gen-2005 Zongaro, S; de Stanchina, E; Colombo, T; D'Incalci, M; Giulotto, E; Mondello, C
Striking activity of E-3810 combined with paclitaxel and 5FU in the triple negative breast cancer model MDA-MB-231 1-gen-2011 Damia, G; Bello, E; Colella, G; Berndt, A; D'Incalci, M; Cavalletti, E; Camboni, G
Tenascin-W is a novel marker for activated tumor stroma in low-grade human breast cancer and influences cell behavior 1-gen-2007 Degen, M; Brellier, F; Kain, R; Ruiz, C; Terracciano, L; Orend, G; CHIQUET-EHRISMANN, R
The anti-HLA-DR monoclonal antibody 1D09C3 activates the mitochondrial cell death pathway and exerts a potent antitumor activity in lymphoma-bearing NOD/SCID mice 1-gen-2006 Carlo-Stella, C.; Di Nicola, M.; Turco, M. C.; Cleris, L.; Lavazza, C.; Longoni, P.; Milanesi, M.; Magni, M.; Ammirante, M.; Leone, A.; Nagy, Z.; Gioffrè, W. R.; Formelli, F.; Gianni, A. M.
The CC chemokine MCP-1/CCL2 in pancreatic cancer progression: Regulation of expression and potential mechanisms of antimalignant activity 1-gen-2003 Monti, P; Leone, Be; Marchesi, F; Balzano, G; Zerbi, A; Scaltrini, F; Pasquali, C; Calori, G; Pessi, F; Sperti, C; Di Carlo, V; Allavena, P; Piemonti, L
TP53 and KRAS2 mutations in plasma DNA of healthy subjects and subsequent cancer occurrence: A prospective study 1-gen-2006 Gormally, E; Vineis, P; Matullo, G; Veglia, F; Caboux, E; Le Roux, E; Peluso, M; Garte, S; Guarrera, S; Munnia, A; Airoldi, L; Autrup, H; Malaveille, C; Dunning, A; Overvad, K; Tjonneland, A; Lund, E; Clavel-Chapelon, F; Boeing, H; Trichopoulou, A; Palli, D; Krogh, V; Tumino, R; Panico, S; Bueno-de-Mesquita, Hb; Peeters, Ph; Pera, G; Martinez, C; Dorronsoro, M; Barricarte, A; Navarro, C; Quiros, Jr; Hallmans, G; Day, Ne; Key, Tj; Saracci, R; Kaaks, R; Riboli, E; Hainaut, P
Mostrati risultati da 70 a 89 di 93
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile